Other adjustments: Additional items are excluded from non-GAAP financial measures because management does not consider them to be related to the core operating activities and ongoing operating performance of Cypress. Excluding these items, which can vary significantly from quarter to quarter, allows management to better compare Cypress’ period-over-period performance. However, limitations of non-GAAP measures that exclude these items include that these adjustments are often subjective and such non-GAAP measures may not be comparable to similarly titled non-GAAP financial measures used by other companies. These adjustments primarily include:
- Revenue from an intellectual property license;
- Changes in value of deferred compensation plan assets and liabilities;
- Investment-related gains or losses, including equity method investments;
- Restructuring and related costs;
- Debt issuance costs, including imputed interest related to the equity component of convertible debt;
- Asset impairments;
- Tax effects of non-GAAP adjustments;
- Income tax adjustment related to the use of the net operating loss, non-cash impact of not asserting indefinite reinvestment on earnings of our foreign subsidiaries, deferred tax expense not affecting taxes payable, and non-cash expense (benefit) related to uncertain tax positions;
- Certain other expenses and benefits; and
- Diluted weighted average shares non-GAAP adjustment - for purposes of calculating non-GAAP diluted earnings per share, the GAAP diluted weighted average shares outstanding is adjusted to include the impact of non-GAAP adjustments on the number of diluted shares underlying stock-based compensation awards and the impact of the capped call options related to the outstanding convertible notes.
Adjusted EBITDA: Adjusted EBITDA is calculated by adjusting net income (loss) attributable to Cypress to exclude (without duplication): interest expense, income tax provision, depreciation, amortization, equity in net loss of equity method investees, and the non-GAAP adjustments described above (acquisition related charges, stock-based compensation expense, and other adjustments). Commencing in the second quarter of 2018, Cypress reconciles adjusted EBITDA to GAAP net income rather than operating income; prior period reconciliation tables have been revised to conform to the current presentation. Adjusted EBITDA may be useful to management, investors and other users of our financial information because the exclusion of certain gains, losses, and expenses facilitates comparisons of Cypress' operating performance on a period to period basis. Adjusted EBITDA should not be considered as a measure of discretionary cash available to invest in the growth of the business. In addition, adjusted EBITDA should not be considered as a substitute for, or superior to net income attributable to Cypress, operating income, or diluted earnings per share, or other financial measures prepared in accordance with GAAP.
Free Cash Flow: Free cash flow is calculated as net cash provided by (used in) operating activities, less acquisition of property, plant and equipment, net (i.e., acquisition of property, plant and equipment less proceeds received from disposition of property, plant and equipment). We consider free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by business operations, after deducting our net payments for acquisitions and dispositions of property and equipment, which cash can then be used for strategic opportunities or other business purposes including, among others, investing in the Company's business, repurchasing stock, making strategic acquisitions, repayment of debt, and strengthening the balance sheet. A limitation of free cash flow is that it does not represent the total increase or decrease in the cash balance for the period. Management compensates for this limitation by also relying on the net increase in cash and cash equivalents and restricted cash as presented in the Company’s condensed consolidated statements of cash flows prepared in accordance with GAAP which incorporates all cash movements during the period.
FORWARD-LOOKING STATEMENTS
Statements in this press release that are not historical facts and that
refer to Cypress or its subsidiaries’ plans and expectations for the
future are forward-looking statements as such term is used in the
Private Securities Litigation Reform Act of 1995. We may use words such
as “may,” "will," “should,” “plan,” “anticipate,” “believe,” “expect,”
“future,” “intend,” “estimate,” “predict,” “potential,” “continue” or
similar expressions identify forward-looking statements. This press
release includes, among others, forward-looking statements regarding our
fourth quarter financial outlook (as well as the related GAAP to
non-GAAP reconciling items). Our forward-looking statements are based on
the expectations, beliefs, and intentions of, and the information
available to, our executive management on the date of this press
release. Forward-looking statements involve risks and uncertainties, and
readers are cautioned not to place undue reliance on forward-looking
statements. Important factors that could cause actual results to differ
materially from those in the forward-looking statements include, but are
not limited to: potential tariffs and other disruptions in the
international trade and investment environment; global economic and
market conditions; our ability to execute on our Cypress 3.0 strategy
and our margin improvement plan; risks related to paying down our
indebtedness and meeting the covenants in our debt agreements; our
efforts to retain and expand our customer base; business conditions and
growth trends in the semiconductor market; competition; volatility in
supply and demand for our products, including but not limited to the
impact of seasonality on supply and demand; our ability to develop,
introduce and sell new products and technologies; potential problems
relating to our manufacturing activities; reliance on distributers,
resellers, third-party manufacturers, and others; risks related to our
“take or pay” agreements with certain vendors; the risk of defects,
errors, or security vulnerabilities in our products; the impact of
acquisitions; our ability to attract and retain key personnel; the
unpredictability and expense of legal proceedings; and other risks and
uncertainties described in the "Risk Factors," "Management's Discussion
and Analysis of Financial Condition and Results of Operations," and
“Quantitative and Qualitative Disclosures about Market Risk” sections in
our most recent Annual Report on Form 10-K and in our subsequent
quarterly filings with the Securities and Exchange Commission which are
available on our investor relations website at
http://investors.cypress.com/financial-information/sec-filings .
We assume no responsibility to update our forward-looking statements.